SMS Lifesciences India Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 540679 |
NSE Symbol : SMSLIFE |
P/E(TTM) : 16.70 |
ISIN Demat : INE320X01016 |
Div & Yield% : 0.12 |
EPS(TTM) : 71.83 |
Book Value(₹) : 621.86 |
Market Cap(₹Cr) : 362.64 |
Face Value(₹) : 10.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 78.50 | 86.57 | 86.37 | 71.23 | 67.84 | 74.56 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 78.50 | 86.57 | 86.37 | 71.23 | 67.84 | 74.56 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.26 | 0.43 | 2.28 | 0.64 | 0.33 | 0.58 |
Total Income | 79.75 | 87.00 | 88.65 | 71.87 | 68.18 | 75.14 |
Total Expenditure | 66.70 | 72.80 | 75.56 | 62.21 | 58.37 | 69.44 |
PBIDT | 13.06 | 14.20 | 13.09 | 9.66 | 9.81 | 5.71 |
Interest | 1.92 | 2.16 | 2.56 | 2.04 | 2.48 | 1.82 |
PBDT | 11.13 | 12.04 | 10.53 | 7.62 | 7.33 | 3.89 |
Depreciation | 2.57 | 2.50 | 2.62 | 2.55 | 2.55 | 2.53 |
Tax | 2.50 | 3.00 | 0.75 | 1.50 | 1.40 | 0.40 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.05 | 0.08 | 1.22 | 0.26 | 0.26 | 0.26 |
Reported Profit After Tax | 6.01 | 6.46 | 5.93 | 3.31 | 3.12 | 0.70 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 6.01 | 6.46 | 5.93 | 3.31 | 3.12 | 0.70 |
EPS (Unit Curr.) | 19.87 | 21.37 | 19.63 | 10.96 | 10.31 | 2.32 |
EPS (Adj) (Unit Curr.) | 19.87 | 21.37 | 19.63 | 10.96 | 10.31 | 2.32 |
Calculated EPS (Unit Curr.) | 19.87 | 21.37 | 19.63 | 10.96 | 10.31 | 2.32 |
Calculated EPS (Adj) (Unit Curr.) | 19.87 | 21.37 | 19.63 | 10.96 | 10.31 | 2.32 |
Calculated EPS (Ann.) (Unit Curr.) | 79.49 | 85.47 | 78.50 | 43.85 | 41.24 | 9.27 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 79.49 | 85.47 | 78.50 | 43.85 | 41.24 | 9.27 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 16.64 | 16.40 | 15.16 | 13.56 | 14.46 | 7.66 |
PBDTM(%) | 14.18 | 13.91 | 12.19 | 10.70 | 10.80 | 5.22 |
PATM(%) | 7.66 | 7.46 | 6.87 | 4.65 | 4.60 | 0.94 |